Sign in

CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company

aTYR PHARMA INC

Sign in to watch
Ticker
ATYR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
203435077
Phone
8587318389
Business address
10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. 8-K Event Executive or director change · Shareholder vote results
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. ARS Other Annual Report to Security Holders
  14. DEFA14A Proxy Proxy Materials
  15. DEF 14A Proxy Proxy Statement
  16. 4 Open-market buy Director bought 3,750 shares at $4.00 ($15,000)
  17. 10-K Report Annual Report
  18. 8-K Event Results of operations
  19. 4 Option exercise President and CEO acquired 10,375 shares (option exercise)
  20. 4 Open-market sale Chief Financial Officer sold 1,254 shares at $3.78 ($4,740)

Page 4 of 38 · 755 filings